Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Published: Sep, 2016 | Pages: 42 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016', provides an overview of the Foamix Pharmaceuticals Ltd.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Foamix Pharmaceuticals Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Foamix Pharmaceuticals Ltd.
- The report provides overview of Foamix Pharmaceuticals Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Foamix Pharmaceuticals Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Foamix Pharmaceuticals Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Foamix Pharmaceuticals Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Foamix Pharmaceuticals Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Foamix Pharmaceuticals Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Foamix Pharmaceuticals Ltd. Snapshot 5
Foamix Pharmaceuticals Ltd. Overview 5
Key Facts 5
Foamix Pharmaceuticals Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Foamix Pharmaceuticals Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Foamix Pharmaceuticals Ltd. - Pipeline Products Glance 14
Foamix Pharmaceuticals Ltd. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Foamix Pharmaceuticals Ltd. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Foamix Pharmaceuticals Ltd. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Foamix Pharmaceuticals Ltd. - Drug Profiles 18
(urea + lactic acid) - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
acyclovir - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
benzoyl peroxide - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
betamethasone valerate - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
ciclopirox olamine - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
doxycycline - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
estradiol hemihydrate - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
FMX-101 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
FMX-102 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
FMX-103 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
imiquimod - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
mometasone furoate - Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
urea - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
Foamix Pharmaceuticals Ltd. - Pipeline Analysis 35
Foamix Pharmaceuticals Ltd. - Pipeline Products by Target 35
Foamix Pharmaceuticals Ltd. - Pipeline Products by Route of Administration 36
Foamix Pharmaceuticals Ltd. - Pipeline Products by Molecule Type 37
Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action 38
Foamix Pharmaceuticals Ltd. - Dormant Projects 39
Foamix Pharmaceuticals Ltd. - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40

Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42

List of Tables

Foamix Pharmaceuticals Ltd., Key Facts 5
Foamix Pharmaceuticals Ltd. - Pipeline by Indication, 2016 8
Foamix Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016 9
Foamix Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016 10
Foamix Pharmaceuticals Ltd. - Combination Treatment Modalities in Pipeline, 2016 11
Foamix Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2016 12
Foamix Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2016 13
Foamix Pharmaceuticals Ltd. - Phase III, 2016 14
Foamix Pharmaceuticals Ltd. - Phase II, 2016 15
Foamix Pharmaceuticals Ltd. - Phase I, 2016 16
Foamix Pharmaceuticals Ltd. - Preclinical, 2016 17
Foamix Pharmaceuticals Ltd. - Pipeline by Target, 2016 35
Foamix Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016 36
Foamix Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016 37
Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016 38
Foamix Pharmaceuticals Ltd. - Dormant Developmental Projects,2016 39
Foamix Pharmaceuticals Ltd., Subsidiaries 40